Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 34

1.

How to Monitor the Neuroimmune Biological Response in Patients Affected by Immune Alteration-Related Systemic Diseases.

Lissoni P, Rovelli F, Vigorè L, Messina G, Lissoni A, Porro G, Di Fede G.

Methods Mol Biol. 2018;1781:171-191. doi: 10.1007/978-1-4939-7828-1_10.

PMID:
29705848
2.

The psychoneuroendocrine-immunotherapy of cancer: Historical evolution and clinical results.

Lissoni P, Messina G, Lissoni A, Franco R.

J Res Med Sci. 2017 Apr 26;22:45. doi: 10.4103/jrms.JRMS_255_16. eCollection 2017. Review.

3.

Therapy implications of the role of interleukin-2 in cancer.

Lissoni P.

Expert Rev Clin Immunol. 2017 May;13(5):491-498. doi: 10.1080/1744666X.2017.1245146. Epub 2016 Oct 26. Review.

PMID:
27782752
5.

Psychoimmunological analysis of cancer patients: correlation with the prognosis.

Messina G, Lissoni P, Rovelli F.

Curr Aging Sci. 2012 Dec;5(3):263-72.

PMID:
23387886
6.

A reinterpretation of the pathogenesis and cure of cancer according to the psychoneuroimmunological discoveries.

Lissoni P.

Methods Mol Biol. 2012;934:183-92. doi: 10.1007/978-1-62703-071-7_10.

PMID:
22933147
7.

Principles of psychoneuroendocrinoimmunotherapy of cancer.

Lissoni P, Rovelli F.

Immunotherapy. 2012 Jan;4(1):77-86. doi: 10.2217/imt.11.158. Review.

PMID:
22150002
8.

Chemotherapy with or without low-dose interleukin-2 in advanced non-small cell lung cancer: results from a phase III randomized multicentric trial.

Ridolfi L, Bertetto O, Santo A, Naglieri E, Lopez M, Recchia F, Lissoni P, Galliano M, Testore F, Porta C, Maglie M, Dall'agata M, Fumagalli L, Ridolfi R.

Int J Oncol. 2011 Oct;39(4):1011-7. doi: 10.3892/ijo.2011.1099. Epub 2011 Jun 24.

PMID:
21720704
9.

Enhancement of the efficacy of cancer chemotherapy by the pineal hormone melatonin and its relation with the psychospiritual status of cancer patients.

Messina G, Lissoni P, Marchiori P, Bartolacelli E, Brivio F, Magotti L.

J Res Med Sci. 2010 Jul;15(4):225-8.

10.

Psychoneuroendocrine modulation of regulatory T lymphocyte system: in vivo and in vitro effects of the pineal immunomodulating hormone melatonin.

Vigoré L, Messina G, Brivio F, Fumagalli L, Rovelli F, DI Fede G, Lissoni P.

In Vivo. 2010 Sep-Oct;24(5):787-9.

PMID:
20952751
11.

Synchronization of cortisol circadian rhythm by the pineal hormone melatonin in untreatable metastatic solid tumor patients and its possible prognostic significance on tumor progression.

Brivio F, Fumagalli L, Fumagalli G, Pescia S, Brivio R, Di Fede G, Rovelli F, Lissoni P.

In Vivo. 2010 Mar-Apr;24(2):239-41.

PMID:
20364003
12.

Oxytocin both increases proliferative response of peripheral blood lymphomonocytes to phytohemagglutinin and reverses immunosuppressive estrogen activity.

Macciò A, Madeddu C, Chessa P, Panzone F, Lissoni P, Mantovani G.

In Vivo. 2010 Mar-Apr;24(2):157-63.

PMID:
20363988
13.
14.

HER2 expression in breast cancer: correlation with endocrine function and psychological status in operable and metastatic breast cancer.

Lissoni P, Messina G, Rovelli F, Brivio F, Fumagalli L, Villa S, Bartolacelli E.

In Vivo. 2009 Nov-Dec;23(6):987-9.

15.

A randomized study of chemotherapy versus biochemotherapy with chemotherapy plus Aloe arborescens in patients with metastatic cancer.

Lissoni P, Rovelli F, Brivio F, Zago R, Colciago M, Messina G, Mora A, Porro G.

In Vivo. 2009 Jan-Feb;23(1):171-5.

16.

The endocannabinoid anandamide neither impairs in vitro T-cell function nor induces regulatory T-cell generation.

Lissoni P, Tintori A, Fumagalli L, Brivio F, Messina G, Parolini D, Biondi A, Balestra A, D'Amico G.

Anticancer Res. 2008 Nov-Dec;28(6A):3743-8.

17.
18.

Pre-operative immunoprophylaxis with interleukin-2 may improve prognosis in radical surgery for colorectal cancer stage B-C.

Brivio F, Fumagalli L, Lissoni P, Nardone A, Nespoli L, Fattori L, Denova M, Chiarelli M, Nespoli A.

Anticancer Res. 2006 Jan-Feb;26(1B):599-603.

19.

Endocrine effects of erythropoietin in cancer patients.

Lissoni P, Perego M, Veronese E, Fumagalli G, Brivio F, Colciago M, Messina G, Rovelli F, Brivio R, Gardani G.

Hematology. 2004 Oct-Dec;9(5-6):363-7.

PMID:
15763975
20.

Total pineal endocrine substitution therapy (TPEST) as a new neuroendocrine palliative treatment of untreatable metastatic solid tumor patients: a phase II study.

Lissoni P, Malugani F, Brivio F, Piazza A, Vintimilla C, Giani L, Tancini G.

Neuro Endocrinol Lett. 2003 Jun-Aug;24(3-4):259-62.

PMID:
14523367

Supplemental Content

Loading ...
Support Center